Board of Directors

Richard J. Clothier - Non-Executive Chairman of the Board
Ronald L. Stotish, PhD - President and Chief Executive Officer 
Elliot Z. Entis - Non-Executive Director and Co-Founder
Richard L. Huber - Non-Executive Director
William Marcus - Non-Executive Director
Eric I. Steiner, MD, MBA - Non-Executive Director
David R. Stevens, DVM, PhD - Non-Executive Director


Richard J. Clothier
Non-Executive Chairman of the Board
Chairman, Nominations and Corporate Governance Committee

Richard J. Clothier has served as Chairman of the Board of Aqua Bounty since the Company’s public offering in 2006. He has also served as Chairman of Robinson Plc since 2004 and of Spearhead International Ltd since 2005. He recently retired as Group Chief Executive of PGI Group Plc, an international agricultural products producer, following 20 years with the Dalgety Plc where he was Group CEO until 1997. He holds a BSc in Agriculture from Natal University and an AMP from Harvard Business School.
Ronald L. Stotish, PhD
President and Chief Executive Officer

Ronald L. Stotish was appointed an Executive Director, President and CEO of Aqua Bounty Technologies in May 2008. Dr. Stotish joined Aqua Bounty in 2006 as Vice President for Regulatory Affairs, and most recently was Senior Vice President for R&D and Regulatory Affairs. Prior to joining Aqua Bounty, Dr. Stotish was Executive Vice President for R&D at MetaMorphix, Inc. He has served as Vice President for Pharmaceutical Research and Development at Fort Dodge Animal Health, and held a variety of positions at American Cyanamid. He began his career in research at Merck. Dr. Stotish has degrees in biochemistry and over thirty eight years experience in the discovery, development, and commercialization of new animal health products.
Elliot Z. Entis
Non-Executive Director and Co-Founder

Elliot Z. Entis is one of the founders of Aqua Bounty and led the Company as its CEO until 2008. He has 20 years of experience in the wholesale seafood industry in Boston and spent ten years heading a research firm in Washington, D.C.. He has served as a member of the national Board of BIO, the association of biotechnology companies, and was chairman of BIO’s Animal Agriculture Board. Mr. Entis has written and spoken extensively on commercial and regulatory issues surrounding the introduction of foods derived with the help of the new tools of biotechnology. He is a 1968 graduate of Harvard College and received his M.A. degree in political science from UC, Berkeley.
Richard L. Huber
Non-Executive Director
Member, Audit Committee

Richard Huber joined the Board of Aqua Bounty after the Company’s public offering in 2006. Mr. Huber is the former Chairman, President and CEO of Aetna, a major US health insurer, and is currently an independent investor in a number of companies operating in a wide range of businesses, mainly in South America. Following a 40 year career in the financial services industry, Mr. Huber now serves as a Director of Covanta Energy, the largest waste-to-energy company in the United States, American Commercial Barge Line, one of the largest transportation operators on the Mississippi River system, Gafisa, the largest integrated residential housing developer in Brazil, and Viña San Rafael of Chile, as well as several other companies in the U.S. and elsewhere in the world. He holds an AB in Chemistry from Harvard.
William M. Marcus
Non-Executive Director
Chairman, Audit Committee

William Marcus has been a Director of Aqua Bounty since the Company’s inception in December 1991. Mr. Marcus is the Executive VP, Treasurer, and a Director of American Biltrite (AMEX). He is also a Director of the Congoleum Corporation. He was for many years the Treasurer of Reebok (NYSE) and was head of its Audit Committee.
Eric I. Steiner, MD, MBA
Non-Executive Director
Member, Compensation Committee

Eric Steiner has been a Director of Aqua Bounty since July 2003. Dr. Steiner is the former President and COO of the Fairchild Corporation. He had been President from 1998 until December 2009. He also held the position of President of The Fairchild Fasteners Division of The Fairchild Corporation from 1995 through 2002, when the Fasteners Division was acquired by The Alcoa Corporation. He is currently an independent investor in a number of companies operating in a wide range of businesses. Dr. Steiner received an M.B.A. in 1990 from INSEAD Graduate School of Business in Fontainebleau, France. Prior to attending INSEAD, he was a resident at the Hospitaux de Paris and earlier was awarded an M.D. from the Faculte de Medicine de Paris.
David R. Stevens, DVM, PhD
Non-Executive Director
Chairman, Compensation Committee

David R. Stevens has been a Director of Aqua Bounty since June 2002. Dr. Stevens has worked in the pharmaceutical and biotechnology industries since 1978. He is currently Chairman of CanCog Technologies, Inc., a contract research organization, Advanced Headache Intervention, Inc., a medical device company, and Cedus, Inc., a development stage biopharmaceutical company. He is also a board member of Advanced Cosmetic Intervention, Inc., and Micro-Imaging Solutions, LLC, both medical device companies. He was an advisor to Bay City Capital from 1999-2006. Dr. Stevens was previously President and CEO of Deprenyl Animal Health, Inc., a veterinary pharmaceutical company, from 1990 to 1998, and Vice President, Research and Development, of Agrion Corp., a biotechnology company, from 1985 to 1988. He began his career in pharmaceutical research and development at the former Upjohn Company, where he contributed to the preclinical evaluation of Xanax and Halcion. Dr. Stevens received BS and DVM degrees from Washington State University, and a PhD in Comparative Pathology from the University of California, Davis. He is a Diplomate of the American College of Veterinary Pathologists.

Back to Top